Requests that the FDA to review whether its regulatory record for the Medtronic Activa/Percept Deep Brain Stimulation system contains sufficient publicly available information to assess long-term material degradation and associated patient safety risks.
🏛 Food and Drug Administration (FDA)FDA-2025-P-7184
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.